Literature DB >> 8790053

Transthoracic echocardiography in models of cardiac disease in the mouse.

N Tanaka1, N Dalton, L Mao, H A Rockman, K L Peterson, K R Gottshall, J J Hunter, K R Chien, J Ross.   

Abstract

BACKGROUND: Transthoracic echocardiography (M-mode and Doppler) offers a noninvasive approach for in vivo evaluation of the mouse heart. The present study examines its usefulness for assessing the morphological/functional phenotype of the left ventricle (LV) in several transgenic and surgical murine models of cardiac disease. METHODS AND
RESULTS: Observations were made in 83 intact, anesthetized mice. In mice with a surgical arteriovenous fistula, volume overload and LV dilation were detected. In normal mice, echocardiographic indexes of increased contractility (dobutamine) were confirmed by LV dP/dtmax. In transgenic mice with overexpression of the beta 2-adrenergic receptor, heart rate and mean velocity of circumferential fiber shortening were increased, indicating enhanced contractility. In colony screening of transgenic mice overexpressing the H-ras gene, 45% had increased LV wall thickness (> 0.9 mm), and those showing a striking increase were selected for breeding. In mice with LV hypertrophy (aortic constriction) and normal mice, the actual LV mass determined by echocardiography correlated well (r = .93), and 95% confidence limits were determined. The maximum intraobserver and interobserver coefficients of variation for M-mode data were 0.03 +/- 0.29 mm (+/- 2 SD), < 10% for LV internal dimensions but 27% to 30% for wall thickness.
CONCLUSIONS: These studies provide the first application of transthoracic echocardiography for morphological/functional characterization of the cardiac phenotype in transgenic and surgical murine models, including (1) high reliability for detecting LV chamber dilation and function; (2) reliability (and its limits) for determining abnormal LV wall thickness and LV mass; (3) identification of marked, sometimes asymmetrical, hypertrophy in a transgenic model of hypertrophic cardiomyopathy; and (4) usefulness for transgenic colony screening to identify markedly abnormal phenotypes.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8790053     DOI: 10.1161/01.cir.94.5.1109

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  101 in total

1.  Transgenic over-expression of a motor protein at high levels results in severe cardiac pathology.

Authors:  J James; H Osinska; T E Hewett; T Kimball; R Klevitsky; S Witt; D G Hall; J Gulick; J Robbins
Journal:  Transgenic Res       Date:  1999-02       Impact factor: 2.788

2.  Oestrogen inhibition reverses pulmonary arterial hypertension and associated metabolic defects.

Authors:  Xinping Chen; Eric D Austin; Megha Talati; Joshua P Fessel; Eric H Farber-Eger; Evan L Brittain; Anna R Hemnes; James E Loyd; James West
Journal:  Eur Respir J       Date:  2017-08-03       Impact factor: 16.671

3.  Genotype, phenotype: upstairs, downstairs in the family of cardiomyopathies.

Authors:  Kenneth R Chien
Journal:  J Clin Invest       Date:  2003-01       Impact factor: 14.808

4.  MTORC1 regulates cardiac function and myocyte survival through 4E-BP1 inhibition in mice.

Authors:  Denghong Zhang; Riccardo Contu; Michael V G Latronico; Jianlin Zhang; Jian Ling Zhang; Roberto Rizzi; Daniele Catalucci; Shigeki Miyamoto; Katherine Huang; Marcello Ceci; Yusu Gu; Nancy D Dalton; Kirk L Peterson; Kun-Liang Guan; Joan Heller Brown; Ju Chen; Nahum Sonenberg; Gianluigi Condorelli
Journal:  J Clin Invest       Date:  2010-07-19       Impact factor: 14.808

5.  Electrocardiographic Characterization of Cardiac Hypertrophy in Mice that Overexpress the ErbB2 Receptor Tyrosine Kinase.

Authors:  Polina Sysa-Shah; Lars L Sørensen; M Roselle Abraham; Kathleen L Gabrielson
Journal:  Comp Med       Date:  2015-08       Impact factor: 0.982

6.  Inactivation of focal adhesion kinase in cardiomyocytes promotes eccentric cardiac hypertrophy and fibrosis in mice.

Authors:  Xu Peng; Marc S Kraus; Huijun Wei; Tang-Long Shen; Romain Pariaut; Ana Alcaraz; Guangju Ji; Lihong Cheng; Qinglin Yang; Michael I Kotlikoff; Ju Chen; Kenneth Chien; Hua Gu; Jun-Lin Guan
Journal:  J Clin Invest       Date:  2005-12-22       Impact factor: 14.808

7.  Akt induces enhanced myocardial contractility and cell size in vivo in transgenic mice.

Authors:  Gianluigi Condorelli; Alessandra Drusco; Giorgio Stassi; Alfonso Bellacosa; Roberta Roncarati; Guido Iaccarino; Matteo A Russo; Yusu Gu; Nancy Dalton; Clarence Chung; Michael V G Latronico; Claudio Napoli; Junichi Sadoshima; Carlo M Croce; John Ross
Journal:  Proc Natl Acad Sci U S A       Date:  2002-09-17       Impact factor: 11.205

8.  Cardiac-specific VLCAD deficiency induces dilated cardiomyopathy and cold intolerance.

Authors:  Dingding Xiong; Huamei He; Jeanne James; Chonan Tokunaga; Corey Powers; Yan Huang; Hanna Osinska; Jeffrey A Towbin; Enkhsaikhan Purevjav; James A Balschi; Sabzali Javadov; Francis X McGowan; Arnold W Strauss; Zaza Khuchua
Journal:  Am J Physiol Heart Circ Physiol       Date:  2013-11-27       Impact factor: 4.733

9.  Muscle-specific VEGF deficiency greatly reduces exercise endurance in mice.

Authors:  I Mark Olfert; Richard A Howlett; Kechun Tang; Nancy D Dalton; Yusu Gu; Kirk L Peterson; Peter D Wagner; Ellen C Breen
Journal:  J Physiol       Date:  2009-02-23       Impact factor: 5.182

10.  Autocrine VEGF signaling is required for vascular homeostasis.

Authors:  Sunyoung Lee; Tom T Chen; Chad L Barber; Maria C Jordan; Jared Murdock; Sharina Desai; Napoleone Ferrara; Andras Nagy; Kenneth P Roos; M Luisa Iruela-Arispe
Journal:  Cell       Date:  2007-08-24       Impact factor: 41.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.